These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2900 related articles for article (PubMed ID: 15118395)

  • 21. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations.
    Pistorius S; Görgens H; Plaschke J; Hoehl R; Krüger S; Engel C; Saeger HD; Schackert HK
    Cancer Lett; 2007 Apr; 248(1):89-95. PubMed ID: 16837128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status.
    Oliveira C; Westra JL; Arango D; Ollikainen M; Domingo E; Ferreira A; Velho S; Niessen R; Lagerstedt K; Alhopuro P; Laiho P; Veiga I; Teixeira MR; Ligtenberg M; Kleibeuker JH; Sijmons RH; Plukker JT; Imai K; Lage P; Hamelin R; Albuquerque C; Schwartz S; Lindblom A; Peltomaki P; Yamamoto H; Aaltonen LA; Seruca R; Hofstra RM
    Hum Mol Genet; 2004 Oct; 13(19):2303-11. PubMed ID: 15294875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low levels of microsatellite instability characterize MLH1 and MSH2 HNPCC carriers before tumor diagnosis.
    Alazzouzi H; Domingo E; González S; Blanco I; Armengol M; Espín E; Plaja A; Schwartz S; Capella G; Schwartz S
    Hum Mol Genet; 2005 Jan; 14(2):235-9. PubMed ID: 15563510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic analysis of microsatellite markers in patients from hereditary nonpolyposis colorectal cancer (HNPCC) families.
    Smolarz B; Romanowicz-Makowska H; Langner E; Kozlowska E; Kulig A; Dziki A
    Exp Oncol; 2004 Sep; 26(3):205-9. PubMed ID: 15494688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.
    Young J; Simms LA; Biden KG; Wynter C; Whitehall V; Karamatic R; George J; Goldblatt J; Walpole I; Robin SA; Borten MM; Stitz R; Searle J; McKeone D; Fraser L; Purdie DR; Podger K; Price R; Buttenshaw R; Walsh MD; Barker M; Leggett BA; Jass JR
    Am J Pathol; 2001 Dec; 159(6):2107-16. PubMed ID: 11733361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.
    Piñol V; Castells A; Andreu M; Castellví-Bel S; Alenda C; Llor X; Xicola RM; Rodríguez-Moranta F; Payá A; Jover R; Bessa X;
    JAMA; 2005 Apr; 293(16):1986-94. PubMed ID: 15855432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes.
    Domingo E; Niessen RC; Oliveira C; Alhopuro P; Moutinho C; Espín E; Armengol M; Sijmons RH; Kleibeuker JH; Seruca R; Aaltonen LA; Imai K; Yamamoto H; Schwartz S; Hofstra RM
    Oncogene; 2005 Jun; 24(24):3995-8. PubMed ID: 15782118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors.
    Hendriks Y; Franken P; Dierssen JW; De Leeuw W; Wijnen J; Dreef E; Tops C; Breuning M; Bröcker-Vriends A; Vasen H; Fodde R; Morreau H
    Am J Pathol; 2003 Feb; 162(2):469-77. PubMed ID: 12547705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer.
    Shia J; Ellis NA; Paty PB; Nash GM; Qin J; Offit K; Zhang XM; Markowitz AJ; Nafa K; Guillem JG; Wong WD; Gerald WL; Klimstra DS
    Am J Surg Pathol; 2003 Nov; 27(11):1407-17. PubMed ID: 14576473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular screening for hereditary nonpolyposis colorectal cancer: a prospective, population-based study.
    Percesepe A; Borghi F; Menigatti M; Losi L; Foroni M; Di Gregorio C; Rossi G; Pedroni M; Sala E; Vaccina F; Roncucci L; Benatti P; Viel A; Genuardi M; Marra G; Kristo P; Peltomäki P; Ponz de Leon M
    J Clin Oncol; 2001 Oct; 19(19):3944-50. PubMed ID: 11579115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC).
    Loukola A; Eklin K; Laiho P; Salovaara R; Kristo P; Järvinen H; Mecklin JP; Launonen V; Aaltonen LA
    Cancer Res; 2001 Jun; 61(11):4545-9. PubMed ID: 11389088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine.
    Planck M; Ericson K; Piotrowska Z; Halvarsson B; Rambech E; Nilbert M
    Cancer; 2003 Mar; 97(6):1551-7. PubMed ID: 12627520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HNPCC: six new pathogenic mutations.
    Kunstmann E; Vieland J; Brasch FE; Hahn SA; Epplen JT; Schulmann K; Schmiegel W
    BMC Med Genet; 2004 Jun; 5():16. PubMed ID: 15217520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ten novel MSH2 and MLH1 germline mutations in families with HNPCC.
    Krüger S; Bier A; Plaschke J; Höhl R; Aust DE; Kreuz FR; Pistorius SR; Saeger HD; Rothhammer V; Al-Taie O; Schackert HK
    Hum Mutat; 2004 Oct; 24(4):351-2. PubMed ID: 15365996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant.
    Berends MJ; Wu Y; Sijmons RH; Mensink RG; van der Sluis T; Hordijk-Hos JM; de Vries EG; Hollema H; Karrenbeld A; Buys CH; van der Zee AG; Hofstra RM; Kleibeuker JH
    Am J Hum Genet; 2002 Jan; 70(1):26-37. PubMed ID: 11709755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer.
    Loughrey MB; Waring PM; Tan A; Trivett M; Kovalenko S; Beshay V; Young MA; McArthur G; Boussioutas A; Dobrovic A
    Fam Cancer; 2007; 6(3):301-10. PubMed ID: 17453358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer.
    Niessen RC; Berends MJ; Wu Y; Sijmons RH; Hollema H; Ligtenberg MJ; de Walle HE; de Vries EG; Karrenbeld A; Buys CH; van der Zee AG; Hofstra RM; Kleibeuker JH
    Gut; 2006 Dec; 55(12):1781-8. PubMed ID: 16636019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer.
    Bapat BV; Madlensky L; Temple LK; Hiruki T; Redston M; Baron DL; Xia L; Marcus VA; Soravia C; Mitri A; Shen W; Gryfe R; Berk T; Chodirker BN; Cohen Z; Gallinger S
    Hum Genet; 1999 Feb; 104(2):167-76. PubMed ID: 10190329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Six novel heterozygous MLH1, MSH2, and MSH6 and one homozygous MLH1 germline mutations in hereditary nonpolyposis colorectal cancer.
    Rey JM; Noruzinia M; Brouillet JP; Sarda P; Maudelonde T; Pujol P
    Cancer Genet Cytogenet; 2004 Dec; 155(2):149-51. PubMed ID: 15571801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 145.